The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome
Abstract
Background: Dopamine agonists could theoretically normalize the suspected central dopamine hypersensitivity in Tourette's syndrome. Methods: There was a multicenter randomized, placebo‐controlled, double‐blind clinical trial of pramipexole given for 6 weeks in 63 children and adolescents with Tourette's syndrome. Results: There were no significant differences in the adjusted mean change in the Total Tic Score of the Yale Global Tic Severity Scale for patients treated with pramipexole (−7.16) and placebo (−7.17). There were no significant treatment effects on change from baseline in the Global Severity score of the Yale Scale and parent‐ and investigator‐scored Clinical Global Impression of Improvement. In patients with attention deficit hyperactivity disorder, there was improvement in DuPaul ADHD scale scores for patients receiving pramipexole compared with placebo. Conclusions: There was no evidence that pramipexole has efficacy in suppressing tics. Pramipexole may decrease symptoms of associated attention deficit hyperactivity disorder. © 2012 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It may decrease symptoms of associated ADHD.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [117]
In the citing paper
“No evidence that pramipexole has efficacy in suppressing tics.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Children's Yale-Brown Obsessive Compulsive Scale: Reliability and Validity
SCAHILL, L., RIDDLE, M. A., McSWIGGIN-HARDIN, M., ORT, S. I., KING, R. A., GOODMAN, W. K., CICCHETTI, D., & LECKMAN, J. F. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199706000-00023 · Cited by 2,045 · cited 1×
“Major exclusion criteria included presence of significant comorbid medical conditions, any psychotic disorder or any other psychiatric disorder severe enough to require medical treatment (comorbid attention deficit hyperactivity disorder [ADHD] and/or obsessive compulsive disorder [OCD] were allowed as long as the pat…”
Dopaminergic dysfunction in tourette syndrome
Singer, H. S., Butler, I. J., Tune, L. E., Seifert, W. E., & Coyle, J. T. (1982) · Annals of Neurology · doi:10.1002/ana.410120408 · Cited by 180
Research works printed but not linked: 18
- 10.1002/ana.410060109 · DOI · Paper page
- 10.1001/archpsyc.1989.01810080052006 · DOI · Paper page
- 10.1212/WNL.34.5.688 · DOI
- 10.1002/mds.870120320 · DOI
- Griesmer DA, 1997, Pergolide in the management of Tourette syndrome, J Child Neurol, 12, 402
- 10.1212/01.WNL.0000123111.00324.BF · DOI
- 10.1212/WNL.54.6.1310 · DOI
- 10.1212/01.WNL.0000044058.64647.7E · DOI · Paper page
- 10.1001/archpsyc.1979.01780090065007 · DOI
- 10.1002/1531-8257(200011)15:6<1194::AID-MDS1019>3.0.CO;2-H · DOI
- 1994, Diagnostic and Statistical Manual of Mental Disorders
- 10.1097/00004583-200001000-00014 · DOI · Paper page
- 10.1097/00004583-198907000-00015 · DOI · Paper page
- Guy W, 1976, ECDEU Assessment Manual for Psychopharmacology, 218
- DuPaul GJ, 1998, ADHD Rating Scale‐IV: Checklists, Norms, and Clinical Interpretation
- Kovacs M, 1992, Technical Manual for the Children's Depression Inventory, 1992
- 10.1097/00004583-199704000-00019 · DOI · Paper page
- Achenbach T. M, 1991, Integrative Guide to the 1991 CBCL/4–18, YSR, and TRF Profiles, 1991
Cited by
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders
Murphy, T. K., Lewin, A. B., Storch, E. A., & Stock, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.015 · Cited by 276
Neuromodulation in Tourette syndrome: dopamine and beyond
Buse, J., Schoenefeld, K., Münchau, A., & Roessner, V. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.004 · Cited by 185
Ganos, C., & Martino, D. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2014.09.008 · Cited by 119
Metadata
- Authors
- Kurlan, R., Crespi, G., Coffey, B., Mueller‐Vahl, K., Koval, S., Wunderlich, G., & on behalf of the Pramipexole for TS Trial Investigators
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2012-03-07
- Volume
- 27
- Issue
- 6
- Pages
- 775-778
- ISSN
- 0885-3185
- 1531-8257
- Cited by
- 48
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome. https://app.cochat.ai/papers/10.1002/mds.24919
- The paper
- Kurlan, R., Crespi, G., Coffey, B., Mueller‐Vahl, K., Koval, S., Wunderlich, G., & on behalf of the Pramipexole for TS Trial Investigators. (2012). A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome. Movement Disorders. https://doi.org/10.1002/mds.24919
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.